Latest News and Press Releases

Investment Accelerates Bredis’ Capacity Expansion, Integrated Platform Development and Commercialization in Korea Further Announcement of Bredis’ Agreements with Major University Hospitals SEOUL,...

SEOUL, Korea and PASADENA, Calif., March 12, 2023 (GLOBE NEWSWIRE) -- Checkmate Capital Group, LLC (“Checkmate”) is pleased to announce the opening of its flagship corporate offices in Seoul, Korea...

Capital to Support Commercialization and Ongoing R&D Engages Checkmate Capital Group as Strategic Advisor PASADENA, Calif. and DALLAS, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Precision Livestock...

LOS ANGELES and SEOUL, South Korea, June 26, 2022 (GLOBE NEWSWIRE) -- A consortium formed by KAIST Venture Investment Holdings and Checkmate Capital Group has been selected as a program operator for...

KT and Hanmi Pharmaceutical to jointly invest in Digital Pharm, a company specializing in digital therapeutics and electroceuticalsLeading the domestic Korean digital therapeutics (DTx) market through...

KT and Hanmi Pharmaceutical to jointly invest in Digital Pharm, a company specializing in digital treatment devices and electronic drugsLeading the domestic Korean digital therapeutics (DTx) market...

PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company developing anti-infective biologics, is pleased to announce the completion of...

To Support Targeted Commercialization and Global Partnering of FDA-Approved Non-Drug Treatment for Pediatric ADHD LOS ANGELES, Sept. 21, 2020 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. (“NeuroSigma”),...

Led by Checkmate Capital Group Development of Biomaterial-based Neurovascular Stent and Platform for Local Delivery of Cell Therapies LOS ANGELES, April 06, 2020 (GLOBE NEWSWIRE) -- Monarch...

LOS ANGELES, March 16, 2020 (GLOBE NEWSWIRE) -- Checkmate Capital Group, LLC (“Checkmate”) is pleased to announce that it is moving its corporate headquarters to new offices in Pasadena,...